Nivalis Therapeutics, Inc. (ALPN)
(Delayed Data from NSDQ)
$6.24 USD
-0.08 (-1.27%)
Updated May 3, 2019 03:59 PM ET
NA Value NA Growth NA Momentum NA VGM
View All Zacks #1 Ranked Stocks
Brokerage Reports
0 items in cart
[ALPN]
Reports for Purchase
Showing records 81 - 100 ( 156 total )
Industry: Medical - Drugs
Partial Clinical Hold for Davoceticept Combo Study; NEON-1Study Unaffected
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Price: 5.00
Industry: Medical - Drugs
NEON-2 Hits Likely Temporary Speed Bump; Stay Tuned as Broad Programs Push Forward
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 12.50
Industry: Medical - Drugs
Potent Triple Threat; Portfolio of Clinical Stage Immunotherapies Builds Momentum
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 12.50
Industry: Medical - Drugs
Price: 25.00
Industry: Medical - Drugs
Nice View on the Horizon for Long-Term Pipeline; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 12.50
Industry: Medical - Drugs
Price: 12.50
Industry: Medical - Drugs
Q3 Financials; ALPN-303 Ph 1 Set to Initiate; Clinical Updates Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Price: 5.00
Industry: Medical - Drugs
2021 Abstract Roundup For Covered CompaniesThis report contains brief updates on the following: ACET, ALPN, ANAB, BCEL, BEAM, CDAK, CTMX, FATE, IGMS, MRSN. These companies are covered in more detail in separate Daily Notes and/or Company Reports.
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Price: 25.00
Industry: Medical - Drugs
3Q21 Results; ALPN-303 Steps Into the Spotlight;
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 12.50
Industry: Medical - Drugs
More Data, More Confidence; ALPN-303 Appears Ready to Enter the Clinic
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 12.50
Industry: Medical - Drugs
Price: 25.00
Industry: Medical - Drugs
Financing Sets up Potential Expansion of Development Plans
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Price: 25.00
Industry: Medical - Drugs
Price: 25.00
Industry: Medical - Drugs
Price: 25.00
Industry: Medical - Drugs
Q2 Financials; ALPN-101 SLE Study Underway; ALPN-202 ASCO Presentation Recap
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Price: 25.00
Industry: Medical - Drugs
2Q21 Results; Pipeline Picks Up Steam With Three Programs at the Helm
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 25.00
Industry: Medical - Drugs
NEON-2 Scores a Clinical Collaborator in Merck; Patient Dosing Begins
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 10.00
Industry: Medical - Drugs
Synergy Trial Gets Going with ALPN-101; Nice Check Cashed from Partner AbbVie
Provider: H.C. Wainwright & Co., Inc.
Analyst: PANTGINIS J
Price: 10.00
Industry: Medical - Drugs
Price: 10.00
Industry: Medical - Drugs
Price: 50.00